Big Move For Lineage Cell Therapeutics, Inc.
Fri, Apr 23, 2021 at 05:33 PM
Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT) shot up at $16.16, a gain of 29.5%. On Thu, Apr 22, 2021, BTX:NYSEMKT touched a New 2-Week High of $12.48. The stock appeared on our News Catalysts scanner on Mon, Apr 19, 2021 at 06:23 PM in the 'PRIVATE PLACEMENT' category. From Thu, Apr 08, 2021, the stock recorded 70.00% Up Days and 45.45% Green Days
About Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT)
BioTime Inc focuses regenerative medicine technologies in ophthalmology, soft tissue reconstruction, and the local delivery of cells and therapeutics.
Top 10 Gainers:
- NDAC (NDAC:NASDAQ), 100%
- Sypris Solutions, Inc. (SYPR:NASDAQ), 59.07%
- Uxin Limited (UXIN:NASDAQ), 58.09%
- MicroVision, Inc. (MVIS:NASDAQ), 36.76%
- Takung Art Co., Ltd. (TKAT:NYSEMKT), 36.65%
- Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT), 29.49%
- FreightCar America, Inc. (RAIL:NASDAQ), 29.26%
- Dolphin Entertainment, Inc. (DLPN:NASDAQ), 28.59%
- 22nd Century Group, Inc. (XXII:NYSEMKT), 28.11%
- Birks Group Inc. (BGI:NYSEMKT), 27.55%